PHARMASKIN UK LIMITEDActive

Company number 10890945Private limited companyIncorporated 2017

Key figures

£19,119+1.8%
Net assets 2025/26
+3.4%
Average annual growth 2019/20–2025/26
05 k10 k15 k20 k2019/202020/212021/222022/232023/242024/252025/26

Like most small UK companies, PHARMASKIN UK LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025/26
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
010 k20 k30 k2019/202020/212021/222022/232023/242024/252025/26
Filed accounts2019/20–2025/26
2021/222022/232023/242024/252025/26
Turnover———3,213—
Profit for the year———373—
Total assets19,50519,88920,60320,93220,234
Total liabilities00001,115
Net assets / total equity17,85417,86018,77718,78319,119
Average number of employees00000

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2026

Other human health activities

As described in the company's latest filed accounts.

Summary: PHARMASKIN UK LIMITED

Company

PHARMASKIN UK LIMITED is a private limited company registered with Companies House under company number 10890945. It was incorporated on 31 Jul 2017. Its status is active. The registered office is in London (WC2H). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2025/26 (period ending 31 Jul 2026); the company files micro-entity accounts. Net assets were £19,119, up 1.8% on the previous year. Total assets were £20,234 and total liabilities £1,115. The company had an average of 0 employees. Figures are available for 7 financial years (2019/20–2025/26).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2028. The next confirmation statement is due by 10 May 2027.